コミナティ筋注5～11歳用の用法・用量追加承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_27677.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
コミナティ筋注5～11歳用の用法・用量追加承認について｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page announces the Ministry of Health, Labour and Welfare's approval on August 30, 2022, of additional dosage and administration instructions for Comirnaty injection for ages 5-11. Developed by Pfizer, this COVID-19 vaccine prevents SARS-CoV-2 infection. The approved dosing includes initial immunization with two 0.2mL doses administered intramuscularly at three-week intervals, followed by a single 0.2mL booster dose. The vaccine is diluted in saline solution prior to administration.
